GLP-1s can help you shed stubborn pounds, especially the kind that shows up during menopause (hi, belly fat)
Further information is available from the NHS, NICE, and the MHRA
Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy
High prevalence of erectile dysfunction in diabetes: A systematic review and meta-analysis of 145 studies
Corporate Presentation Peptide's Explained A Bright Future Ahead
Liraglutide A retrospective observational study investigated 158 obese patients with T2D who were treated with LIRA (starting from a daily dose of 0.6 mg that was increased over 1 week to 1.2 mg/day) at least 3 months before study enrolment [69]